Clinical Trials Browser

Metastatic Colorectal Adenocarcinoma × regorafenib × Clear all

NCT05942768 2023-07-12

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Gastrointestinal

Metastatic Colorectal Adenocarcinoma